ES2137513T3 - Utilizacion de hierro aplicable por via intravenosa para la terapia de enfermedades tumorales y/o enfermedades infecciosas. - Google Patents

Utilizacion de hierro aplicable por via intravenosa para la terapia de enfermedades tumorales y/o enfermedades infecciosas.

Info

Publication number
ES2137513T3
ES2137513T3 ES95918533T ES95918533T ES2137513T3 ES 2137513 T3 ES2137513 T3 ES 2137513T3 ES 95918533 T ES95918533 T ES 95918533T ES 95918533 T ES95918533 T ES 95918533T ES 2137513 T3 ES2137513 T3 ES 2137513T3
Authority
ES
Spain
Prior art keywords
diseases
via intravenous
intravenous therapy
infectious diseases
iron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918533T
Other languages
English (en)
Inventor
Freiherr Von Nagell Helmut Rau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2137513T3 publication Critical patent/ES2137513T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBE LA UTILIZACION DE HIERRO ADMINISTRADO INTRAVENOSAMENTE PARA LA TERAPIA DE ENFERMEDADES TUMORALES Y/O INFECCIOSAS. SE HA DESCUBIERTO, QUE EL ENRIQUECIMIENTO EN HIERRO ADMINISTRADO INTRAVENOSAMENTE TIENE DE MANERA SORPRENDENTE CONSECUENCIAS CURATIVAS EN ENFERMEDADES TUMORALES Y TAMBIEN EN ENFERMEDADES INFECCIOSAS.
ES95918533T 1994-06-01 1995-05-17 Utilizacion de hierro aplicable por via intravenosa para la terapia de enfermedades tumorales y/o enfermedades infecciosas. Expired - Lifetime ES2137513T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4419256A DE4419256A1 (de) 1994-06-01 1994-06-01 Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten

Publications (1)

Publication Number Publication Date
ES2137513T3 true ES2137513T3 (es) 1999-12-16

Family

ID=6519591

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918533T Expired - Lifetime ES2137513T3 (es) 1994-06-01 1995-05-17 Utilizacion de hierro aplicable por via intravenosa para la terapia de enfermedades tumorales y/o enfermedades infecciosas.

Country Status (8)

Country Link
EP (1) EP0788355B1 (es)
AT (1) ATE184790T1 (es)
AU (1) AU2444695A (es)
DE (2) DE4419256A1 (es)
DK (1) DK0788355T3 (es)
ES (1) ES2137513T3 (es)
GR (1) GR3031505T3 (es)
WO (1) WO1995032711A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600744A1 (de) * 1996-01-11 1997-07-17 Werner Alois Prof Dipl Kaiser Magnetische Substanz zur lokalen hyperthermischen Behandlung vorwiegend kleiner Tumore

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
CH625125A5 (en) * 1975-09-26 1981-09-15 Biokema Sa Method for manufacturing a stable injectable solution of immunoglobulins and organic iron, and product obtained by this method
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
GB1546177A (en) * 1976-11-19 1979-05-16 Biokema Sa Process for the preparation of a stable injectable solution
GB2024007B (en) * 1978-06-30 1983-04-27 Gordon R T Cancer-treating composition containing inductively heatable particles
EP0227593A1 (en) * 1985-11-25 1987-07-01 The Hospital For Sick Children Use of chelating agents
GB8607137D0 (en) * 1986-03-21 1986-04-30 Efamol Ltd Compositions
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
DE3842143A1 (de) * 1988-12-15 1990-06-21 Nitsche Dietrich Verwendung von transferrin zur endotoxinneutralisation
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
DE4117782C2 (de) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
FR2677885B1 (fr) * 1991-06-20 1994-08-26 Rocher Labo Biolog Vegetale Y Composition a base de plantes, utilisable en cosmetologie, en hygiene ou en pharmacie et son procede de preparation.
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤

Also Published As

Publication number Publication date
DE4419256A1 (de) 1995-12-07
GR3031505T3 (en) 2000-01-31
ATE184790T1 (de) 1999-10-15
EP0788355A1 (de) 1997-08-13
EP0788355B1 (de) 1999-09-22
AU2444695A (en) 1995-12-21
DK0788355T3 (da) 2000-03-20
WO1995032711A1 (de) 1995-12-07
DE59506911D1 (de) 1999-10-28

Similar Documents

Publication Publication Date Title
BR0009647A (pt) Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
BG101118A (en) Therapeutical compounds
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
ATE328599T1 (de) Antitumorale mittel
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
MX9302038A (es) Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s.
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
PH31441A (en) 5.Substituted derivatives of mycophenolic acid.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69821498D1 (de) Verwendung von amifostin
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
AP9801286A0 (en) Therapeutic compounds.
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
AR022116A1 (es) Terapia de combinacion para el vhc por induccion de ribavirina - interferon alfa
MD990258A (en) Method of treatment of the acute viral hepatitis B
PT1076561E (pt) Terapia de combinacao para o tratamento de tumores
ES2137513T3 (es) Utilizacion de hierro aplicable por via intravenosa para la terapia de enfermedades tumorales y/o enfermedades infecciosas.
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE60008293D1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
ATE293983T1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
TH23210A (th) "อนุพันธุ์พลาวินใช้เป็นสารต่อต้านไวรัส"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 788355

Country of ref document: ES